Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2010-8-30
pubmed:abstractText
A potentially useful trianionic ligand for the reduction of dinitrogen catalytically by molybdenum complexes is one in which one of the arms in a [(RNCH(2)CH(2))(3)N](3-) ligand is replaced by a 2-mesitylpyrrolyl-alpha-methyl arm, that is, [(RNCH(2)CH(2))(2)NCH(2)(2-MesitylPyrrolyl)](3-) (R = C(6)F(5), 3,5-Me(2)C(6)H(3), or 3,5-t-Bu(2)C(6)H(3)). Compounds have been prepared that contain the ligand in which R = C(6)F(5) ([C(6)F(5)N)(2)Pyr](3-)); they include [(C(6)F(5)N)(2)Pyr]Mo(NMe(2)), [(C(6)F(5)N)(2)Pyr]MoCl, [(C(6)F(5)N)(2)Pyr]MoOTf, and [(C(6)F(5)N)(2)Pyr]MoN. Compounds that contain the ligand in which R = 3,5-t-Bu(2)C(6)H(3) ([Ar(t-Bu)N)(2)Pyr](3-)) include {[(Ar(t-Bu)N)(2)Pyr]Mo(N(2))}Na(15-crown-5), {[(Ar(t-Bu)N)(2)Pyr]Mo(N(2))}[NBu(4)], [(Ar(t-Bu)N)(2)Pyr]Mo(N(2)) (nu(NN) = 2012 cm(-1) in C(6)D(6)), {[(Ar(t-Bu)N)(2)Pyr]Mo(NH(3))}BPh(4), and [(Ar(t-Bu)N)(2)Pyr]Mo(CO). X-ray studies are reported for [(C(6)F(5)N)(2)Pyr]Mo(NMe(2)), [(C(6)F(5)N)(2)Pyr]MoCl, and [(Ar(t-Bu)N)(2)Pyr]MoN. The [(Ar(t-Bu)N)(2)Pyr]Mo(N(2))(0/-) reversible couple is found at -1.96 V (in PhF versus Cp(2)Fe(+/0)), but the [(Ar(t-Bu)N)(2)Pyr]Mo(N(2))(+/0) couple is irreversible. Reduction of {[(Ar(t-Bu)N)(2)Pyr]Mo(NH(3))}BPh(4) under Ar at approximately -1.68 V at a scan rate of 900 mV/s is not reversible. Ammonia in [(Ar(t-Bu)N)(2)Pyr]Mo(NH(3)) can be substituted for dinitrogen in about 2 h if 10 equiv of BPh(3) are present to trap the ammonia that is released. [(Ar(t-Bu)N)(2)Pyr]Mo-N=NH is a key intermediate in the proposed catalytic reduction of dinitrogen that could not be prepared. Dinitrogen exchange studies in [(Ar(t-Bu)N)(2)Pyr]Mo(N(2)) suggest that steric hindrance by the ligand may be insufficient to protect decomposition of [(Ar(t-Bu)N)(2)Pyr]Mo-N=NH through a variety of pathways. Three attempts to reduce dinitrogen catalytically with [(Ar(t-Bu)N)(2)Pyr]Mo(N) as a "catalyst" yielded an average of 1.02 +/- 0.12 equiv of NH(3).
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-11006545, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-11843596, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-12033849, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-12215645, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-12562193, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-12633073, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-12843387, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-13878063, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-14677959, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-14871129, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15132641, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15137780, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15496079, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15766240, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15847407, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-15859292, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16288507, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16359167, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16363831, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16417365, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16786542, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-16933911, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17083216, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17083217, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17085586, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17309262, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17614310, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17792182, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-17854184, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-18357978, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-18803409, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-18925739, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-19046077, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-19209938, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-19488434, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-19727472, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-20571574, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-21124377, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-8393705, http://linkedlifedata.com/resource/pubmed/commentcorrection/20799738-8430077
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1520-510X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
6
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7904-16
pubmed:dateRevised
2011-9-13
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Synthesis of diamidopyrrolyl molybdenum complexes relevant to reduction of dinitrogen to ammonia.
pubmed:affiliation
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural